Comparative Effects of Silymarin and Vitamin E Supplementation on Oxidative Stress Markers, and Hemoglobin Levels Among Patients on Hemodialysis

REFERENCES

• Locatelli F, Del Vecchio L, Manzoni C. Morbidity and mortality on maintenance haemodialysis. Nephron. 1998;80(4): 380–400.
   Google Scholar
• Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290(13):697–701.
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl. 3):S112–S119.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens. 2003;12(6):593–598.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Heimbürger O, Paultre F, Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899–1911.
   PubMed Web of Science ®Google Scholar
• Maggi E, Bellazzi R, Falaschi F, Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int. 1994;45(3):876–883.
   Google Scholar
• Galle J, Seibold S, Wanner C. Inflammation in uremic patients: What is the link? Kidney Blood Press Res. 2003;26(2): 65–75.
   Google Scholar
• Kalantar-Zadeh K, Kopple JD, Kamranpour N, Fogelman AM, Navab M. HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int. 2007;72(9): 1149–1156.
   PubMed Web of Science ®Google Scholar
• Haklar G, Yegenaga I, Yalcin AS. Evaluation of oxidant stress in chronic hemodialysis patients: Use of different parameters. Clin Chim Acta. 1995;234(1–2):109–114.
   Google Scholar
• Jackson P, Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem. 1995;41(8 Pt 1): 1135–1138.
   Google Scholar
• Loughrey CM, Young IS, Kightbody JH, Oxidative stress in haemodialysis. QJM. 1994;87(11):679–683.
   Google Scholar
• Homsi E, de Brito SM, Janino P. Silymarin exacerbates p53-mediated tubular apoptosis in glycerol-induced acute kidney injury in rats. Ren Fail. 2010;32(5):623–632.
   PubMed Web of Science ®Google Scholar
• Tunca R, Sozmen M, Citil M, Karapehlivan M, Erginsoy S, Yapar K. Pyridine induction of cytochrome P450 1A1, iNOS and metallothionein in Syrian hamsters and protective effects of silymarin. Exp Toxicol Pathol. 2009;61(3):243–255.
   Google Scholar
• Senturk H, Kabay S, Bayramoglu G. Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney. World J Urol. 2008;26(4): 401–407.
   PubMed Web of Science ®Google Scholar
• Varzi HN, Esmailzadeh S, Morovvati H, Avizeh R, Shahriari A, Givi ME. Effect of silymarin and vitamin E on gentamicin-induced nephrotoxicity in dogs. J Vet Pharmacol Ther. 2007;30(5):477–481.
   PubMed Web of Science ®Google Scholar
• Kaur G, Athar M, Alam MS. Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion response. Invest New Drugs. 2010;28(5):703–713.
   Google Scholar
• Soto C, Pérez J, García V, Uría E, Vadillo M, Raya L. Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus. Phytomedicine. 2010;17(14):1090–1094. Epub 2010 Jun 25.
   PubMed Web of Science ®Google Scholar
• Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006;124(5):491–504.
   PubMed Web of Science ®Google Scholar
• Sonnenbichler J, Scalera F, Sonnenbichler I, Weyhenmeyer R. Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells. J Pharmacol Exp Ther. 1999;290(3):1375–1383.
   PubMed Web of Science ®Google Scholar
• Dietzmann J, Thiel U, Ansorge S, Neumann KH, Täger M. Thiol-inducing and immunoregulatory effects of flavonoids in peripheral blood mononuclear cells from patients with end‐stage diabetic nephropathy. Free Radic Biol Med. 2002;33(10): 1347–1354.
   Google Scholar
• Kren V, Walterova D. Silybin and silymarin – New effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149(1):29–41.
   PubMedGoogle Scholar
• Zal F, Mostafavi-Pour Z, Vessal M. Comparison of the effects of vitamin E and/or quercetin in attenuating chronic cyclosporine A-induced nephrotoxicity in male rats. Clin Exp Pharmacol Physiol. 2007;34(8):720–724.
   PubMedGoogle Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158–169.
   PubMed Web of Science ®Google Scholar
• Giray B, Kan E, Bali M, Hincal F, Basaran N. The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients. Clin Chim Acta. 2003;338(1–2):91–98.
   Google Scholar
• Uzum A, Toprak O, Gumustas MK, Ciftci S, Sen S. Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis. J Nephrol. 2006;19(6):739–745.
   Google Scholar
• Bayes B, Pastor MC, Bonal J, Juncà J, Romero R. Homocysteine and lipid peroxidation in haemodialysis: Role of folinic acid and vitamin E. Nephrol Dial Transplant. 2001;16(11): 2172–2175.
   Google Scholar
• Cristol JP, Bose JY, Badiou S, Erythropoietin and oxidative stress in haemodialysis: Beneficial effects of vitamin E supplementation. Nephrol Dial Transplant. 1997;12(11): 2312–2317.
   PubMedGoogle Scholar
• Giardini O, Taccone-Gallucci M, Lubrano R, Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Nephron. 1984;36(4):235–237.
   Google Scholar
• Durmaz R, Inal M, Angin K, Atasoy MA, Altinisik M, Tel E. The effects of MK-801 and U-83836E on post-ischemic reperfusion injury in rat brain. Acta Neurobiol Exp (Wars). 1999;59(2):99–104.
   Google Scholar
• Miguel A, Miguel A, Linares M . Evidence of an increased susceptibility to lipid peroxidation in red blood cells of chronic renal failure patients. Nephron. 1988;50(1):64–65.
   Google Scholar
• Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis. 2000;150(1):217–224.
   Google Scholar
• Antoniadi G, Eleftheriadis T, Liakopoulos V, Effect of one-year oral alpha-tocopherol administration on the antioxidant defense system in hemodialysis patients. Ther Apher Dial. 2008;12(3):237–242.
   PubMedGoogle Scholar
• Galli F, Rovidati S, Chiarantini L, Campus G, Canestrari F, Buoncristiani U. Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int. 1998;54(2):580–589.
   Google Scholar
• Galli F, Varga Z, Balla J, Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int Suppl. 2001;78:S148–S154.
   Google Scholar
• Huseini HF, Larijani B, Heshmat R, The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: A randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 2006;20(12):1036–1039.
   PubMed Web of Science ®Google Scholar
• Eaton JW, Leida MN. Hemolysis in chronic renal failure. Semin Nephrol. 1985;5(2):133–139.
   Google Scholar
• Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP. Overproduction of reactive oxygen species in end-stage renal disease patients: A potential component of hemodialysis-associated inflammation. Hemodial Int. 2005;9(1): 37–46.
   PubMedGoogle Scholar
• Jacob HS, Eaton JW, Yawata Y, Shortened red blood cell survival in uremic patients: Beneficial and deleterious effects of dialysis. Kidney Int Suppl. 1975;2:139–143.
   Google Scholar
• Eschbach JW. The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int. 1989;35(1):134–148.
   PubMed Web of Science ®Google Scholar
• Eschbach JW, Adamson JW. Anemia of end-stage renal disease (ESRD). Kidney Int. 1985;28(1):1–5.
   Google Scholar
• Wu SG, Jeng FR, Wei SY, Red blood cell osmotic fragility in chronically hemodialyzed patients. Nephron. 1998;78(1): 28–32.
   PubMedGoogle Scholar
• Usberti M, Gerardi G, Micheli A, Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients. J Nephrol. 2002;15(5): 558–564.
   Google Scholar
• Usberti M, Lima G, Arisi M, Bufano G, D'Avanzo L, Gazzotti RM. Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients. J Nephrol. 1997;10(5):261–265.
   Google Scholar